Huadong Medicine Co., Ltd (SHE:000963)
China
· Delayed Price · Currency is CNY 38.85
+1.44 (3.85%)
Apr 30, 2025, 3:04 PM CST
Huadong Medicine Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 41,833 | 41,508 | 40,261 | 37,489 | 34,418 | 33,604 | Upgrade
|
| Other Revenue | 397.3 | 397.3 | 362.43 | 226 | 145.56 | 78.83 | Upgrade
|
| Revenue | 42,231 | 41,906 | 40,624 | 37,715 | 34,563 | 33,683 | Upgrade
|
| Revenue Growth (YoY) | 3.20% | 3.16% | 7.71% | 9.12% | 2.61% | -4.97% | Upgrade
|
| Cost of Revenue | 28,137 | 28,006 | 27,468 | 25,686 | 23,969 | 22,555 | Upgrade
|
| Gross Profit | 14,094 | 13,899 | 13,156 | 12,028 | 10,595 | 11,128 | Upgrade
|
| Selling, General & Admin | 7,723 | 7,806 | 8,066 | 7,584 | 6,591 | 6,969 | Upgrade
|
| Research & Development | 1,659 | 1,426 | 1,271 | 1,016 | 979.64 | 926.73 | Upgrade
|
| Other Operating Expenses | 243.69 | 214.72 | 203.41 | 205.31 | 176.11 | 184.37 | Upgrade
|
| Operating Expenses | 9,738 | 9,558 | 9,566 | 8,873 | 7,788 | 8,103 | Upgrade
|
| Operating Income | 4,356 | 4,341 | 3,590 | 3,155 | 2,806 | 3,025 | Upgrade
|
| Interest Expense | -99.82 | -96.95 | -114.91 | -120.04 | -68.48 | -68.64 | Upgrade
|
| Interest & Investment Income | 107.4 | 104 | 94.05 | 103.35 | 80.4 | 60.99 | Upgrade
|
| Currency Exchange Gain (Loss) | -2.56 | -2.56 | -1.04 | -34.7 | -2.27 | -10.04 | Upgrade
|
| Other Non Operating Income (Expenses) | -58.15 | -27.16 | -29.65 | -27.16 | -31.93 | -16.68 | Upgrade
|
| EBT Excluding Unusual Items | 4,303 | 4,318 | 3,538 | 3,076 | 2,784 | 2,990 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | -2.92 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -124.63 | -129.19 | -233.47 | -113.09 | -96.31 | -27.53 | Upgrade
|
| Gain (Loss) on Sale of Assets | -21.53 | -5.46 | 4.32 | 8.26 | -0.03 | 322.64 | Upgrade
|
| Asset Writedown | -25.19 | -25.19 | -5.14 | -5.87 | -5.09 | -2.51 | Upgrade
|
| Other Unusual Items | 206.56 | 143.19 | 161.87 | 65.6 | 147.89 | 170.41 | Upgrade
|
| Pretax Income | 4,338 | 4,302 | 3,466 | 3,031 | 2,828 | 3,453 | Upgrade
|
| Income Tax Expense | 790.35 | 807.33 | 619.59 | 498.5 | 488.91 | 543.67 | Upgrade
|
| Earnings From Continuing Operations | 3,548 | 3,494 | 2,846 | 2,533 | 2,339 | 2,910 | Upgrade
|
| Minority Interest in Earnings | 16.48 | 17.92 | -7.54 | -33.41 | -37 | -89.86 | Upgrade
|
| Net Income | 3,564 | 3,512 | 2,839 | 2,499 | 2,302 | 2,820 | Upgrade
|
| Net Income to Common | 3,564 | 3,512 | 2,839 | 2,499 | 2,302 | 2,820 | Upgrade
|
| Net Income Growth | 20.99% | 23.71% | 13.59% | 8.58% | -18.38% | 0.24% | Upgrade
|
| Shares Outstanding (Basic) | 1,752 | 1,752 | 1,750 | 1,750 | 1,750 | 1,750 | Upgrade
|
| Shares Outstanding (Diluted) | 1,754 | 1,753 | 1,752 | 1,750 | 1,750 | 1,750 | Upgrade
|
| Shares Change (YoY) | 0.15% | 0.08% | 0.10% | 0.00% | -0.00% | 0.00% | Upgrade
|
| EPS (Basic) | 2.03 | 2.00 | 1.62 | 1.43 | 1.32 | 1.61 | Upgrade
|
| EPS (Diluted) | 2.03 | 2.00 | 1.62 | 1.43 | 1.32 | 1.61 | Upgrade
|
| EPS Growth | 20.81% | 23.61% | 13.47% | 8.58% | -18.37% | 0.24% | Upgrade
|
| Free Cash Flow | 1,508 | 2,021 | 2,323 | 1,189 | 2,351 | 1,938 | Upgrade
|
| Free Cash Flow Per Share | 0.86 | 1.15 | 1.33 | 0.68 | 1.34 | 1.11 | Upgrade
|
| Dividend Per Share | 0.930 | 0.930 | 0.580 | 0.290 | 0.290 | 0.230 | Upgrade
|
| Dividend Growth | 60.35% | 60.35% | 100.00% | - | 26.09% | -17.86% | Upgrade
|
| Gross Margin | 33.37% | 33.17% | 32.38% | 31.89% | 30.65% | 33.04% | Upgrade
|
| Operating Margin | 10.32% | 10.36% | 8.84% | 8.37% | 8.12% | 8.98% | Upgrade
|
| Profit Margin | 8.44% | 8.38% | 6.99% | 6.63% | 6.66% | 8.37% | Upgrade
|
| Free Cash Flow Margin | 3.57% | 4.82% | 5.72% | 3.15% | 6.80% | 5.75% | Upgrade
|
| EBITDA | 5,112 | 5,091 | 4,318 | 3,778 | 3,316 | 3,456 | Upgrade
|
| EBITDA Margin | 12.11% | 12.15% | 10.63% | 10.02% | 9.59% | 10.26% | Upgrade
|
| D&A For EBITDA | 755.77 | 750.15 | 727.64 | 622.73 | 509.65 | 431 | Upgrade
|
| EBIT | 4,356 | 4,341 | 3,590 | 3,155 | 2,806 | 3,025 | Upgrade
|
| EBIT Margin | 10.32% | 10.36% | 8.84% | 8.37% | 8.12% | 8.98% | Upgrade
|
| Effective Tax Rate | 18.22% | 18.77% | 17.88% | 16.45% | 17.29% | 15.74% | Upgrade
|
| Revenue as Reported | 42,231 | 41,906 | 40,624 | 37,715 | 34,563 | 33,683 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.